AbCellera Biologics (ABCL) Gross Margin (2021 - 2023)
AbCellera Biologics' (ABCL) quarterly Gross Margin came in at 100.0% in Q4 2023, up 696.0% YoY from 12.56% in Q4 2022, and little changed on a QoQ basis from 100.0% in Q3 2023.
AbCellera Biologics (ABCL) Gross Margin (2021 - 2023) Analysis & Trends
AbCellera Biologics (ABCL) has 3 years of Gross Margin data on file, last reported at 100.0% in Q4 2023.
- Quarterly Gross Margin rose 696.0% year-over-year to 100.0% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 100.0% (up 1367.0% YoY) and the FY2024 annual result came in at 100.0%, changed 0.0% from the prior year.
- Gross Margin was little changed at 100.0% in Q4 2023, from 100.0% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 100.0% in Q3 2021 to a low of 84.29% in Q4 2021.
- A 3-year average of 92.85% and a median of 91.58% in 2021 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin tumbled 1480 bps — and 2023, when it surged 1480 bps.
- Tracing ABCL's Gross Margin over 3 years: stood at 84.29% in 2021, then grew by 10 bps to 93.04% in 2022, then rose by 7 bps to 100.0% in 2023.
- The last three Gross Margin figures came in at 100.0% (Q4 2023), 100.0% (Q3 2023), and 100.0% (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 90.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 89.76% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 60,631,834.75% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 76.90% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 84.20% |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 100.00% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | 100.00% |
| Mar 31, 2023 | 100.00% |
| Dec 31, 2022 | 93.04% |
| Sep 30, 2022 | 85.20% |
| Jun 30, 2022 | 88.65% |
| Mar 31, 2022 | 85.90% |
| Dec 31, 2021 | 84.29% |
| Sep 30, 2021 | 100.00% |
| Jun 30, 2021 | 86.94% |
| Mar 31, 2021 | 90.13% |